S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LUCD Lucid Diagnostics Inc

0.9239

0.00 (0.00%)

Pre Market

Last Updated: 21:16:28

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Lucid Diagnostics (NASDAQ:LUCD)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Lucid Diagnostics Charts.

Lucid Diagnostics (NASDAQ:LUCD)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Lucid Diagnostics Charts.

Lucid Diagnostics Inc News

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume
Monday 13 January 2025 (3 weeks ago) • PR Newswire (US)

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Tuesday 24 December 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Saturday 21 December 2024 (1 month ago) • Edgar (US Regulatory)

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters
Friday 20 December 2024 (1 month ago) • PR Newswire (US)

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
Thursday 12 December 2024 (2 months ago) • PR Newswire (US)

Form D - Notice of Exempt Offering of Securities
Saturday 7 December 2024 (2 months ago) • Edgar (US Regulatory)

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones
Wednesday 4 December 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Saturday 30 November 2024 (2 months ago) • Edgar (US Regulatory)

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test
Wednesday 20 November 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Tuesday 19 November 2024 (2 months ago) • PR Newswire (US)

PAVmed Provides Business Update and Third Quarter 2024 Financial Results
Friday 15 November 2024 (3 months ago) • PR Newswire (US)

More Lucid Diagnostics Inc News Articles

International Bank for R...

WisdomTree Commodity Sec...

Deutsche Bank Luxembourg

Intesa Sanpaolo

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions